| UniProt ID | UBA1_MOUSE | |
|---|---|---|
| UniProt AC | Q02053 | |
| Protein Name | Ubiquitin-like modifier-activating enzyme 1 | |
| Gene Name | Uba1 | |
| Organism | Mus musculus (Mouse). | |
| Sequence Length | 1058 | |
| Subcellular Localization | Cytoplasm . Mitochondrion . Nucleus . | |
| Protein Description | Catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation through the ubiquitin-proteasome system. [PubMed: 1511901 Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a ubiquitin-E1 thioester and free AMP. Essential for the formation of radiation-induced foci, timely DNA repair and for response to replication stress. Promotes the recruitment of TP53BP1 and BRCA1 at DNA damage sites.] | |
| Protein Sequence | MSSSPLSKKRRVSGPDPKPGSNCSPAQSALSEVSSVPTNGMAKNGSEADIDESLYSRQLYVLGHEAMKMLQTSSVLVSGLRGLGVEIAKNIILGGVKAVTLHDQGTTQWADLSSQFYLREEDIGKNRAEVSQPRLAELNSYVPVTAYTGPLVEDFLSSFQVVVLTNSPLEAQLRVGEFCHSRGIKLVVADTRGLFGQLFCDFGEEMVLTDSNGEQPLSAMVSMVTKDNPGVVTCLDEARHGFETGDFVSFSEVQGMIQLNGCQPMEIKVLGPYTFSICDTSNFSDYIRGGIVSQVKVPKKISFKSLPASLVEPDFVMTDFAKYSRPAQLHIGFQALHQFCALHNQPPRPRNEEDATELVGLAQAVNARSPPSVKQNSLDEDLIRKLAYVAAGDLAPINAFIGGLAAQEVMKACSGKFMPIMQWLYFDALECLPEDKEALTEEKCLPRQNRYDGQVAVFGSDFQEKLSKQKYFLVGAGAIGCELLKNFAMIGLGCGEGGEVVVTDMDTIEKSNLNRQFLFRPWDVTKLKSDTAAAAVRQMNPYIQVTSHQNRVGPDTERIYDDDFFQNLDGVANALDNIDARMYMDRRCVYYRKPLLESGTLGTKGNVQVVIPFLTESYSSSQDPPEKSIPICTLKNFPNAIEHTLQWARDEFEGLFKQPAENVNQYLTDSKFVERTLRLAGTQPLEVLEAVQRSLVLQRPQTWGDCVTWACHHWHTQYCNNIRQLLHNFPPDQLTSSGAPFWSGPKRCPHPLTFDVNNTLHLDYVMAAANLFAQTYGLTGSQDRAAVASLLQSVQVPEFTPKSGVKIHVSDQELQSANASVDDSRLEELKATLPSPDKLPGFKMYPIDFEKDDDSNFHMDFIVAASNLRAENYDISPADRHKSKLIAGKIIPAIATTTAAVVGLVCLELYKVVQGHQQLDSYKNGFLNLALPFFGFSEPLAAPRHQYYNQEWTLWDRFEVQGLQPNGEEMTLKQFLDYFKTEHKLEITMLSQGVSMLYSFFMPAAKLKERLDQPMTEIVSRVSKRKLGRHVRALVLELCCNDESGEDVEVPYVRYTIR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MSSSPLSKK ------CCCCCCCCC | 51.32 | - | |
| 2 | Phosphorylation | ------MSSSPLSKK ------CCCCCCCCC | 51.32 | 23527152 | |
| 3 | Phosphorylation | -----MSSSPLSKKR -----CCCCCCCCCC | 48.08 | 25266776 | |
| 4 | Phosphorylation | ----MSSSPLSKKRR ----CCCCCCCCCCC | 38.87 | 23527152 | |
| 7 | Phosphorylation | -MSSSPLSKKRRVSG -CCCCCCCCCCCCCC | 39.24 | 25367039 | |
| 13 | Phosphorylation | LSKKRRVSGPDPKPG CCCCCCCCCCCCCCC | 42.68 | 25521595 | |
| 21 | Phosphorylation | GPDPKPGSNCSPAQS CCCCCCCCCCCHHHH | 43.10 | 25521595 | |
| 24 | Phosphorylation | PKPGSNCSPAQSALS CCCCCCCCHHHHHHH | 27.76 | 25521595 | |
| 28 | Phosphorylation | SNCSPAQSALSEVSS CCCCHHHHHHHHHCC | 33.03 | 25521595 | |
| 31 | Phosphorylation | SPAQSALSEVSSVPT CHHHHHHHHHCCCCC | 35.35 | 22942356 | |
| 34 | Phosphorylation | QSALSEVSSVPTNGM HHHHHHHCCCCCCCC | 22.90 | 25619855 | |
| 35 | Phosphorylation | SALSEVSSVPTNGMA HHHHHHCCCCCCCCC | 36.97 | 25619855 | |
| 38 | Phosphorylation | SEVSSVPTNGMAKNG HHHCCCCCCCCCCCC | 42.10 | 25619855 | |
| 41 | Oxidation | SSVPTNGMAKNGSEA CCCCCCCCCCCCCCC | 5.35 | 17242355 | |
| 46 | Phosphorylation | NGMAKNGSEADIDES CCCCCCCCCCCCCHH | 38.72 | 25521595 | |
| 53 | Phosphorylation | SEADIDESLYSRQLY CCCCCCHHHHHHHHH | 28.94 | 25619855 | |
| 55 | Phosphorylation | ADIDESLYSRQLYVL CCCCHHHHHHHHHHH | 15.87 | 25619855 | |
| 56 | Phosphorylation | DIDESLYSRQLYVLG CCCHHHHHHHHHHHH | 20.88 | 25619855 | |
| 60 | Phosphorylation | SLYSRQLYVLGHEAM HHHHHHHHHHHHHHH | 5.81 | 25367039 | |
| 131 | Phosphorylation | GKNRAEVSQPRLAEL CCCCHHCCCCCHHHH | 26.44 | 22802335 | |
| 179 | S-palmitoylation | QLRVGEFCHSRGIKL HHHHHHHHHHCCCEE | 2.18 | 26165157 | |
| 185 | Ubiquitination | FCHSRGIKLVVADTR HHHHCCCEEEEECCC | 37.74 | - | |
| 234 | S-nitrosocysteine | DNPGVVTCLDEARHG CCCCCEEEEHHHCCC | 2.81 | - | |
| 234 | S-nitrosylation | DNPGVVTCLDEARHG CCCCCEEEEHHHCCC | 2.81 | 24926564 | |
| 278 | S-palmitoylation | GPYTFSICDTSNFSD CCEEEEEECCCCHHH | 4.53 | 28680068 | |
| 281 | Phosphorylation | TFSICDTSNFSDYIR EEEEECCCCHHHHCC | 23.72 | - | |
| 296 | Ubiquitination | GGIVSQVKVPKKISF CCCCCCCCCCCCCCC | 45.22 | - | |
| 299 | Ubiquitination | VSQVKVPKKISFKSL CCCCCCCCCCCCCCC | 66.77 | - | |
| 302 | Phosphorylation | VKVPKKISFKSLPAS CCCCCCCCCCCCCHH | 35.19 | 30387612 | |
| 304 | Ubiquitination | VPKKISFKSLPASLV CCCCCCCCCCCHHHC | 44.27 | - | |
| 322 | Ubiquitination | FVMTDFAKYSRPAQL EEEECHHHCCCCCEE | 43.69 | - | |
| 340 | Glutathionylation | FQALHQFCALHNQPP HHHHHHHHHHCCCCC | 2.95 | 24333276 | |
| 356 | Phosphorylation | PRNEEDATELVGLAQ CCCHHHHHHHHHHHH | 42.02 | 28464351 | |
| 369 | Phosphorylation | AQAVNARSPPSVKQN HHHHHCCCCCCCCCC | 38.46 | 26824392 | |
| 374 | Ubiquitination | ARSPPSVKQNSLDED CCCCCCCCCCCCCHH | 48.37 | - | |
| 377 | Phosphorylation | PPSVKQNSLDEDLIR CCCCCCCCCCHHHHH | 34.40 | 25521595 | |
| 385 | Ubiquitination | LDEDLIRKLAYVAAG CCHHHHHHHHHHHHC | 30.40 | - | |
| 388 | Phosphorylation | DLIRKLAYVAAGDLA HHHHHHHHHHHCCCH | 10.89 | - | |
| 443 | Ubiquitination | KEALTEEKCLPRQNR HHHHCCCCCCCCCCC | 34.53 | - | |
| 465 | Acetylation | FGSDFQEKLSKQKYF ECHHHHHHHHCCCEE | 47.48 | 23954790 | |
| 465 | Ubiquitination | FGSDFQEKLSKQKYF ECHHHHHHHHCCCEE | 47.48 | - | |
| 481 | S-palmitoylation | VGAGAIGCELLKNFA ECCCHHHHHHHHHCE | 2.45 | 26165157 | |
| 526 | Ubiquitination | FRPWDVTKLKSDTAA CCCCCHHHCCHHHHH | 54.49 | - | |
| 528 | Acetylation | PWDVTKLKSDTAAAA CCCHHHCCHHHHHHH | 48.09 | 23806337 | |
| 528 | Succinylation | PWDVTKLKSDTAAAA CCCHHHCCHHHHHHH | 48.09 | 23806337 | |
| 528 | Succinylation | PWDVTKLKSDTAAAA CCCHHHCCHHHHHHH | 48.09 | - | |
| 528 | Ubiquitination | PWDVTKLKSDTAAAA CCCHHHCCHHHHHHH | 48.09 | - | |
| 531 | Phosphorylation | VTKLKSDTAAAAVRQ HHHCCHHHHHHHHHH | 25.86 | - | |
| 542 | Phosphorylation | AVRQMNPYIQVTSHQ HHHHHCCEEEEEECC | 10.05 | 25367039 | |
| 593 | Ubiquitination | RRCVYYRKPLLESGT CCCCEEECCCHHCCC | 24.72 | - | |
| 600 | Phosphorylation | KPLLESGTLGTKGNV CCCHHCCCCCCCCCE | 31.15 | 25338131 | |
| 604 | Ubiquitination | ESGTLGTKGNVQVVI HCCCCCCCCCEEEEE | 46.84 | - | |
| 627 | Ubiquitination | SSQDPPEKSIPICTL CCCCCCCCCCCEEEE | 60.50 | - | |
| 628 | Phosphorylation | SQDPPEKSIPICTLK CCCCCCCCCCEEEEC | 31.75 | 22324799 | |
| 635 | Ubiquitination | SIPICTLKNFPNAIE CCCEEEECCCCCHHH | 38.09 | - | |
| 657 | Ubiquitination | DEFEGLFKQPAENVN HHHHHHHCCCCHHHH | 61.49 | - | |
| 668 | Phosphorylation | ENVNQYLTDSKFVER HHHHHHHCCHHHHHH | 33.04 | 28464351 | |
| 670 | Phosphorylation | VNQYLTDSKFVERTL HHHHHCCHHHHHHHH | 23.82 | 18779572 | |
| 671 | Acetylation | NQYLTDSKFVERTLR HHHHCCHHHHHHHHH | 57.13 | 23806337 | |
| 671 | Malonylation | NQYLTDSKFVERTLR HHHHCCHHHHHHHHH | 57.13 | 26320211 | |
| 671 | Ubiquitination | NQYLTDSKFVERTLR HHHHCCHHHHHHHHH | 57.13 | - | |
| 746 | Ubiquitination | APFWSGPKRCPHPLT CCCCCCCCCCCCCCE | 70.88 | - | |
| 793 | Phosphorylation | AVASLLQSVQVPEFT HHHHHHHHCCCCCCC | 17.94 | 23737553 | |
| 800 | Phosphorylation | SVQVPEFTPKSGVKI HCCCCCCCCCCCCEE | 28.30 | 25266776 | |
| 802 | Acetylation | QVPEFTPKSGVKIHV CCCCCCCCCCCEEEE | 57.70 | 23806337 | |
| 802 | Ubiquitination | QVPEFTPKSGVKIHV CCCCCCCCCCCEEEE | 57.70 | - | |
| 803 | Phosphorylation | VPEFTPKSGVKIHVS CCCCCCCCCCEEEEC | 50.45 | 26745281 | |
| 806 | Malonylation | FTPKSGVKIHVSDQE CCCCCCCEEEECHHH | 30.53 | 26320211 | |
| 806 | Ubiquitination | FTPKSGVKIHVSDQE CCCCCCCEEEECHHH | 30.53 | - | |
| 810 | Phosphorylation | SGVKIHVSDQELQSA CCCEEEECHHHHHHC | 21.29 | 25521595 | |
| 816 | Phosphorylation | VSDQELQSANASVDD ECHHHHHHCCCCCCH | 35.79 | 27087446 | |
| 820 | Phosphorylation | ELQSANASVDDSRLE HHHHCCCCCCHHHHH | 26.36 | 27087446 | |
| 824 | Phosphorylation | ANASVDDSRLEELKA CCCCCCHHHHHHHHH | 34.01 | 25619855 | |
| 832 | Phosphorylation | RLEELKATLPSPDKL HHHHHHHHCCCCCCC | 37.30 | 27180971 | |
| 835 | Phosphorylation | ELKATLPSPDKLPGF HHHHHCCCCCCCCCC | 49.17 | 25521595 | |
| 838 | Acetylation | ATLPSPDKLPGFKMY HHCCCCCCCCCCEEE | 61.02 | 23236377 | |
| 838 | Ubiquitination | ATLPSPDKLPGFKMY HHCCCCCCCCCCEEE | 61.02 | - | |
| 843 | Ubiquitination | PDKLPGFKMYPIDFE CCCCCCCEEEECCCC | 43.36 | - | |
| 851 | Ubiquitination | MYPIDFEKDDDSNFH EEECCCCCCCCCCCC | 67.46 | - | |
| 873 | Phosphorylation | SNLRAENYDISPADR CCCCCCCCCCCHHHH | 13.22 | 29899451 | |
| 876 | Phosphorylation | RAENYDISPADRHKS CCCCCCCCHHHHHHH | 15.90 | 25521595 | |
| 882 | Ubiquitination | ISPADRHKSKLIAGK CCHHHHHHHHHHHCC | 50.62 | - | |
| 883 | Phosphorylation | SPADRHKSKLIAGKI CHHHHHHHHHHHCCH | 26.94 | - | |
| 889 | Ubiquitination | KSKLIAGKIIPAIAT HHHHHHCCHHHHHHH | 28.57 | - | |
| 923 | Ubiquitination | HQQLDSYKNGFLNLA HHHHHHHHCCCCCEE | 55.32 | - | |
| 971 | Phosphorylation | QPNGEEMTLKQFLDY CCCCCEECHHHHHHH | 33.80 | 23140645 | |
| 980 | Acetylation | KQFLDYFKTEHKLEI HHHHHHHHHCCHHHH | 46.93 | - | |
| 1044 | Phosphorylation | ELCCNDESGEDVEVP HHHCCCCCCCCCCCC | 50.80 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UBA1_MOUSE !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UBA1_MOUSE !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBA1_MOUSE !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SYCP1_HUMAN | SYCP1 | physical | 20360068 | |
| UBA1_HUMAN | UBA1 | physical | 20360068 | |
| PIP_HUMAN | PIP | physical | 20360068 |
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-24; SER-31;SER-816; SER-820 AND SER-835, AND MASS SPECTROMETRY. | |
| "Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry."; Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.; J. Proteome Res. 6:250-262(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46, AND MASSSPECTROMETRY. | |
| "Quantitative time-resolved phosphoproteomic analysis of mast cellsignaling."; Cao L., Yu K., Banh C., Nguyen V., Ritz A., Raphael B.J., Kawakami Y.,Kawakami T., Salomon A.R.; J. Immunol. 179:5864-5876(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-55, AND MASSSPECTROMETRY. | |